Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
Does not yet support clinical PTEN inhibition; leaves open translation of PI3K/Akt modulation to ischaemia/reperfusion trials.
Mocanu et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: